Investors |


LexaGene interview on CDX beta results

LexaGene CEO Dr. Jack Regan discusses the beta testing LexaGene completed with CDX Analytics for rapid pathogen detection in cannabis and hemp. Watch video.  

Watch video

LexaGene discusses ASL beta testing for Human Clinical

LexaGene CEO Dr. Jack Regan discusses beta testing client Assurance Scientific Laboratories (ASL) and their plans to use the LX Analyzer prototype in human clinical diagnostics. Watch video.  

Watch video

BioSpace article on LexaGene antibiotic resistance testing

Read BioSpace article on LexaGene’s news: The CDC and FDA AR Isolate Bank will provide information to LexaGene which will support the company’s diagnostics development and help address the serious issue of antibiotic resistance.

Read More

LexaGene discusses FDA AR Isolate Bank

LexaGene discusses recent approval by CDC and FDA Antibiotic Resistance Isolate Bank to receive samples for testing. Watch video.  

Watch video

Interview on filing three additional patents

LexaGene CEO Dr. Jack Regan discusses the recent filing of three additional patents and plans for the company. Watch video.  

Read More

Interview on Antibiotic Resistance Panel

Dr. Jack Regan discusses LexaGene’s development of an antibiotic resistance panel to detect antibiotic resistance in pathogens in just one hour.

Read More

LexaGene featured on Uptick Newswire

LexaGene President Daryl Rebeck joins Uptick News to discuss developing a commercialized and easy to use genetic analyzer for use in multiple markets.

Read More

NJ Cannabis Insider | Q&A with Dr. Regan

NJ Cannabis Insider chats with Dr. Regan about LexaGene’s ability to address the testing needs of the cannabis market.

Read More

LexaGene featured on Capital Ideas TV

LexaGene CEO feat. on Capital Ideas TV

LexaGene CEO and Founder Dr. Jack Regan was featured recently on Capital Ideas Media. Watch now for an update on upcoming plans for the company.

Read More

LexaGene featured on

LexaGene featured on describing how the company is setting the bar high for food safety testing in an article entitled: The Food Industry is in Desperate Need of Innovation When it Comes to Pathogen Testing. Read Article

Read More

WCVB feature

WCVB-TV Boston Feature

LexaGene was featured on ABC-affiliated television station WCVB Boston on a segment of ‘Cutting Edge’ on December 21, 2018. Watch now!  

Watch Now

Top Ten Food Solution Provider

LexaGene has been voted among the “10 Most Promising Food and Beverages Solution Providers 2018” by CIOReview based on the company’s pathogen detection system, the LX2™ Genetic Analyzer. Read feature article in CIOReview.

Read More